Oxytocin vs Thymosin Beta-4 Fragment (TB4-Frag 17-23)
A neutral, side-by-side comparison of two healing & recovery peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Oxytocin
Endogenous 9-amino acid neuropeptide produced in the hypothalamus with roles in social bonding, trust, and childbirth. Research applications span wound healing, anti-inflammatory effects, sexual function, anxiety reduction, and autonomic nervous system regulation. Intranasal administration crosses the blood-brain barrier and is the primary research route for behavioral and neurological applications.
Full profileThymosin Beta-4 Fragment (TB4-Frag 17-23)
The heptapeptide fragment (amino acids 17–23) of full thymosin beta-4, sequence Ac-LKKTETQ. This sequence is the active actin-binding domain responsible for TB-500's tissue repair properties. Shorter molecular weight than TB-500 enables more targeted delivery while retaining identical mechanism of action on G-actin regulation and tissue repair signaling.
Full profile| Oxytocin | Thymosin Beta-4 Fragment (TB4-Frag 17-23) | |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Also known as | OT, Pitocin, Syntocinon, trust hormone, bonding peptide | TB4 fragment 17-23, TB-500 active peptide, LKKTETQ, thymosin beta-4 fragment, Ac-LKKTETQ |
| Evidence | Research-stage | Research-stage |
| Dosing range | 10–20IU–100–160IU IU, Intranasal 30–60 minutes pre-activity; 1–2x daily for wound healing or anti-inflammatory protocols | 250mcg–1mg mcg–mg, 2–3x weekly |
| Administration | Intranasal spray, Subcutaneous injection, Intravenous (clinical) | Subcutaneous injection, Intramuscular injection |
| Key side effects | Nausea, Headache, Transient hypotension, Hyponatremia (high IV doses — water retention effect) | Injection site irritation, Mild fatigue (transient), Potential headache, Generally well-tolerated in research applications |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: Oxytocin — Intranasal spray, Subcutaneous injection, Intravenous (clinical); Thymosin Beta-4 Fragment (TB4-Frag 17-23) — Subcutaneous injection, Intramuscular injection.
- Dosing units differ: Oxytocin is dosed in IU, Thymosin Beta-4 Fragment (TB4-Frag 17-23) in mcg–mg — they operate at different scales.
- Frequency: Oxytocin is typically Intranasal 30–60 minutes pre-activity; 1–2x daily for wound healing or anti-inflammatory protocols; Thymosin Beta-4 Fragment (TB4-Frag 17-23) is 2–3x weekly.
How each works
Oxytocin
Oxytocin binds oxytocin receptors (OTR) throughout the brain and periphery, producing prosocial, anxiolytic, and anti-inflammatory effects. The landmark 2005 Kosfeld et al. Nature study demonstrated that intranasal oxytocin increased trust in humans in economic game paradigms. Peripheral effects include acceleration of wound healing, modulation of inflammatory cytokines, and parasympathetic nervous system activation.
Thymosin Beta-4 Fragment (TB4-Frag 17-23)
The LKKTETQ sequence was identified in 1994 as the minimum active fragment of thymosin beta-4 responsible for its actin-sequestering and tissue repair activity. This heptapeptide competes with actin monomer binding proteins, promoting cell migration, angiogenesis, and wound healing. Studies confirm it recapitulates the key bioactivity of full TB4 in cell migration and collagen deposition assays.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.